Creso Pharma Signs LOI With ImpActive For Further Growth

Creso Pharma (ASX: CPH) this morning announced that it has signed a non-binding letter of intent with that of ImpACTIVE Holdings. The LOI outlines the distribution of a suite of hemp CBD based products, CannaDOL and cannaQIX, in both Canada and the United States.

The arrangement will see both of Creso’s hemp based CBD products meant for human consumption distributed by ImpActive, which is a Canadian firm focused on reducing muscle and joint inflammation, particularly as they related to sports injuries. ImpActive itself has developed a number of CBD products focused on removing the use of narcotics or prescription pharmaceuticals for such injuries.

Under the terms of the non-binding letter of intent, both Creso and ImpActive have agreed to enter a formal commercial agreement by April 1, 2021. The commercial agreement is to determine the terms under which both CannaDOL and cannaQIX will be distributed, with Creso also to become an authorized distributor of ImpActive’s CBD based roll on products in Switzerland and Europe.

“We are very proud to enter the sports and recreational market with such a high calibre partner as ImpACTIVE. This LOI is important for Creso Pharma, as it further broadens our international footprint and provides another large market opportunity.”

Jorge Wernli, Commercial Director of Creso Pharma

The initial term of the arrangement is currently pegged at one year, with an automatic renewal for a second year.

Cambria Gold Mines — sponsored Sponsored · Cambria Gold Mines

Creso Pharma last traded at $0.20 on the ASX.


FULL DISCLOSURE: Creso Pharma is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Creso Pharma on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Epic Gold Outlines 150,700 Indicated Ounces at 2.26 G/T in Updated Benoist Resource

Related News

Mernova: Creso Pharm’s Licensed Cannabis Producer – The Daily Dive feat Jack Yu

Today on the Daily Dive, we sit down with Jack Yu, managing director of Mernova...

Thursday, February 11, 2021, 01:30:00 PM

Creso Pharma Enters LOI For Product Distribution In The USA

Creso Pharma (ASX: CPH) is the latest issuer to enter the US cannabis market. The...

Monday, March 1, 2021, 07:25:54 AM

Red Light Holland, Creso Pharma Walk From Merger Due To COVID Headwinds

Red Light Holland (CSE: TRIP) and Creso Pharma (ASX: CPH) evidently have elected to walk...

Monday, August 30, 2021, 09:12:37 AM

Creso Pharma Sees Canadian Subsidiary Secure Numerous Purchase Orders

Creso Pharma (ASX: CPH) this morning announced that it has secured a number of new...

Thursday, February 4, 2021, 07:03:33 AM

Bruce Linton: Will Cannabis Be Descheduled Under Biden? – The Daily Dive

Today on the Daily Dive, we get the opportunity to sit down with Bruce Linton,...

Tuesday, February 9, 2021, 01:30:00 PM